open access

Vol 13, No 5 (2006): Folia Cardiologica
Original articles
Published online: 2006-05-25
Get Citation

Echocardiography findings in patients with ST segment elevation myocardial infarction and type 2 diabetes mellitus treated with primary percutaneous coronary angioplasty

Leszek Markuszewski, Robert Pietruszyński, Grzegorz Kamiński, Włodzimierz Grabowicz
Folia Cardiol 2006;13(5):414-418.

open access

Vol 13, No 5 (2006): Folia Cardiologica
Original articles
Published online: 2006-05-25

Abstract

Background: The development of heart failure following myocardial infarction (MI) in patients with diabetes mellitus (DM) is related to the extent of the infarction zone and underlying primary diabetic cardiomyopathy. Echocardiography allows the monitoring of systolic dysfunction following MI. Left ventricular ejection fraction (LVEF) is one of the most important prognostic indicators in patients after MI.
Methods: The aim of the study was to assess the effect of type 2 DM on postinfarct left ventricular (LV) remodeling in patients with acute ST segment elevation MI treated with primary percutaneous transluminal coronary angioplasty. One hundred and ten patients were enrolled to the study and divided into two groups: group 1 included 41 subjects with type 2 DM, and group 2 included 57 subjects without DM. Echocardiographic parameters of LV systolic function including LVEF, LV end-diastolic volume (LVEDV), and LV end-systolic volume (LVESV) were compared between the study groups.
Results: Both study groups showed statistically significant decrease in LVEF. However, significant LV dilatation was seen only in patients without DM but not in patients with DM.
Conclusion: Long-term DM leads to the remodeling and the fibrosis of cardiac interstitial tissue, limiting acute ventricular dilatation and resulting in stiffening of the heart.

Abstract

Background: The development of heart failure following myocardial infarction (MI) in patients with diabetes mellitus (DM) is related to the extent of the infarction zone and underlying primary diabetic cardiomyopathy. Echocardiography allows the monitoring of systolic dysfunction following MI. Left ventricular ejection fraction (LVEF) is one of the most important prognostic indicators in patients after MI.
Methods: The aim of the study was to assess the effect of type 2 DM on postinfarct left ventricular (LV) remodeling in patients with acute ST segment elevation MI treated with primary percutaneous transluminal coronary angioplasty. One hundred and ten patients were enrolled to the study and divided into two groups: group 1 included 41 subjects with type 2 DM, and group 2 included 57 subjects without DM. Echocardiographic parameters of LV systolic function including LVEF, LV end-diastolic volume (LVEDV), and LV end-systolic volume (LVESV) were compared between the study groups.
Results: Both study groups showed statistically significant decrease in LVEF. However, significant LV dilatation was seen only in patients without DM but not in patients with DM.
Conclusion: Long-term DM leads to the remodeling and the fibrosis of cardiac interstitial tissue, limiting acute ventricular dilatation and resulting in stiffening of the heart.
Get Citation

Keywords

diabetes mellitus; remodeling; primary angioplasty; myocardial infarction; echocardiography; ejection fraction

About this article
Title

Echocardiography findings in patients with ST segment elevation myocardial infarction and type 2 diabetes mellitus treated with primary percutaneous coronary angioplasty

Journal

Cardiology Journal

Issue

Vol 13, No 5 (2006): Folia Cardiologica

Pages

414-418

Published online

2006-05-25

Bibliographic record

Folia Cardiol 2006;13(5):414-418.

Keywords

diabetes mellitus
remodeling
primary angioplasty
myocardial infarction
echocardiography
ejection fraction

Authors

Leszek Markuszewski
Robert Pietruszyński
Grzegorz Kamiński
Włodzimierz Grabowicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl